Meeder Asset Management Inc. boosted its stake in DENTSPLY SIRONA Inc (NASDAQ:XRAY) by 101.3% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 41,285 shares of the medical instruments supplier’s stock after buying an additional 20,771 shares during the period. Meeder Asset Management Inc.’s holdings in DENTSPLY SIRONA were worth $2,409,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds also recently modified their holdings of the company. Hanseatic Management Services Inc. bought a new position in shares of DENTSPLY SIRONA during the first quarter valued at approximately $30,000. Cornerstone Advisors Inc. increased its stake in shares of DENTSPLY SIRONA by 62.0% during the second quarter. Cornerstone Advisors Inc. now owns 904 shares of the medical instruments supplier’s stock valued at $53,000 after purchasing an additional 346 shares in the last quarter. Arcadia Investment Management Corp MI bought a new position in shares of DENTSPLY SIRONA during the second quarter valued at approximately $58,000. Private Capital Group LLC increased its stake in shares of DENTSPLY SIRONA by 74.7% during the first quarter. Private Capital Group LLC now owns 1,223 shares of the medical instruments supplier’s stock valued at $61,000 after purchasing an additional 523 shares in the last quarter. Finally, Quadrant Capital Group LLC increased its stake in shares of DENTSPLY SIRONA by 1,047.2% during the first quarter. Quadrant Capital Group LLC now owns 1,411 shares of the medical instruments supplier’s stock valued at $68,000 after purchasing an additional 1,288 shares in the last quarter. Institutional investors and hedge funds own 94.13% of the company’s stock.
Shares of XRAY traded up $0.10 on Tuesday, hitting $53.63. 11,523 shares of the stock traded hands, compared to its average volume of 1,976,455. The company has a market capitalization of $11.73 billion, a PE ratio of 26.63, a P/E/G ratio of 1.91 and a beta of 0.97. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.39 and a current ratio of 2.08. The business has a 50 day simple moving average of $55.23 and a 200 day simple moving average of $51.80. DENTSPLY SIRONA Inc has a one year low of $33.93 and a one year high of $59.40.
DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings results on Friday, August 2nd. The medical instruments supplier reported $0.66 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.62 by $0.04. The company had revenue of $1.01 billion during the quarter, compared to the consensus estimate of $1.04 billion. DENTSPLY SIRONA had a net margin of 2.67% and a return on equity of 9.19%. The firm’s quarterly revenue was down 3.1% compared to the same quarter last year. During the same quarter last year, the firm earned $0.60 earnings per share. On average, equities analysts expect that DENTSPLY SIRONA Inc will post 2.39 earnings per share for the current year.
In related news, CEO Donald M. Jr. Casey bought 10,000 shares of the business’s stock in a transaction on Wednesday, May 29th. The stock was acquired at an average price of $53.68 per share, with a total value of $536,800.00. Following the transaction, the chief executive officer now owns 105,631 shares in the company, valued at approximately $5,670,272.08. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director Betsy D. Holden bought 2,720 shares of the business’s stock in a transaction on Thursday, June 6th. The stock was bought at an average cost of $55.31 per share, with a total value of $150,443.20. Following the transaction, the director now owns 9,224 shares in the company, valued at approximately $510,179.44. The disclosure for this purchase can be found here. Insiders have purchased 22,720 shares of company stock valued at $1,223,243 in the last three months. 0.62% of the stock is owned by insiders.
A number of equities analysts have weighed in on the stock. BidaskClub raised shares of DENTSPLY SIRONA from a “sell” rating to a “hold” rating in a research note on Friday. Wellington Shields raised shares of DENTSPLY SIRONA from a “hold” rating to a “gradually accumulate” rating in a research note on Friday, August 2nd. Barrington Research reaffirmed a “buy” rating and set a $63.00 target price on shares of DENTSPLY SIRONA in a research note on Monday, August 5th. Zacks Investment Research downgraded shares of DENTSPLY SIRONA from a “buy” rating to a “hold” rating and set a $62.00 target price for the company. in a research note on Monday, May 27th. Finally, Wolfe Research assumed coverage on shares of DENTSPLY SIRONA in a research note on Thursday, May 30th. They set a “peer perform” rating for the company. Nine research analysts have rated the stock with a hold rating and four have issued a buy rating to the company’s stock. The stock has a consensus rating of “Hold” and a consensus price target of $54.57.
DENTSPLY SIRONA Profile
DENTSPLY SIRONA Inc designs, develops, manufactures, and markets various dental and oral health products, and other consumable healthcare products primarily for the professional dental market worldwide. The company operates in two segments, Technologies & Equipment; and Consumables. Its dental supplies include endodontic instruments and materials, dental anesthetics, prophylaxis pastes, dental sealants, impression materials, restorative materials, tooth whiteners, and topical fluoride products; and small equipment products comprise dental hand pieces, intraoral curing light systems, dental diagnostic systems, and ultrasonic scalers and polishers.
See Also: Return on Equity (ROE)
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.